-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Researchers at Mount Sinai made two important discoveries
Advanced bladder cancer is aggressive and patients usually have a poor
When people develop cancer, a type of immune cell called a "natural killer cell" starts acting in an attempt to kill tumor cells
To make more killer cells, the researchers showed that they could induce CD8+ T cells to express a molecule called NKG2A on their surface, making them behave more like natural killer cells
The second finding concerned the ability of cancer cells to
Dr.
"Immune checkpoint blockade is a major type of cancer immunotherapy that targets the PD1-PDL1 pathway to reactivate 'depleted' CD8+ T cells to fight tumors," said co-corresponding author Nina Bhardwaj, Ph.
To conduct the study, the researchers analyzed the tumors and blood of patients at different stages of bladder cancer and studied all samples after the patients had been surgically removed to ensure they were able to capture live immune cells and examine their function
Original:
Is bin-opening in cockatoos leading to an innovation arms race with humans?